These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18196658)

  • 1. Resistance to aspirin and clopidogrel: possible mechanisms, laboratory investigation, and clinical significance.
    Papathanasiou A; Goudevenos J; Tselepis AD
    Hellenic J Cardiol; 2007; 48(6):352-63. PubMed ID: 18196658
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    de Lemos JA; McGuire DK
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572580
    [No Abstract]   [Full Text] [Related]  

  • 3. Effective platelet inhibition by aspirin and clopidogrel: where are we now?
    Tousoulis D; Briasoulis A; Dhamrait SS; Antoniades C; Stefanadis C
    Heart; 2009 May; 95(10):850-8. PubMed ID: 19401288
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin and clopidogrel resistance-a myth or reality: an update.
    Gupta S; Gupta MM
    Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
    [No Abstract]   [Full Text] [Related]  

  • 5. [Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery].
    Griffo R
    Ital Heart J Suppl; 2001 May; 2(5):553-5. PubMed ID: 11388335
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Armstrong EC
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572582
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Akinlade BK
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12571267
    [No Abstract]   [Full Text] [Related]  

  • 8. [Resistance to antiplatelet drugs in patients with non ST elevation acute coronary syndrome].
    Aĭnetdinova DKh; Udovichenko AE; Sulimov VA
    Kardiologiia; 2008; 48(6):35-9. PubMed ID: 18729834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Yaes RJ
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572584
    [No Abstract]   [Full Text] [Related]  

  • 10. CURE works patients with acute coronary syndromes at all risk levels.
    SoRelle R
    Circulation; 2002 Sep; 106(13):e9035-6. PubMed ID: 12270880
    [No Abstract]   [Full Text] [Related]  

  • 11. Clopidogrel resistance: a new chapter in a fast-moving story.
    Wiviott SD; Antman EM
    Circulation; 2004 Jun; 109(25):3064-7. PubMed ID: 15226220
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin and clopidogrel resistance: possible mechanisms and clinical relevance. Part I: Concept of resistance.
    Vadász D; Sztriha LK; Sas K; Vecsei L
    Ideggyogy Sz; 2012 Nov; 65(11-12):377-85. PubMed ID: 23289172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel].
    Helø OH; Madsen JK; Kastrup J
    Ugeskr Laeger; 2004 Apr; 166(18):1659-62. PubMed ID: 15174400
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Ramsey SD
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572583
    [No Abstract]   [Full Text] [Related]  

  • 15. Clopidogrel in acute coronary syndromes: can the cost effectiveness improve?
    Sánchez-Delgado E
    Circulation; 2003 Aug; 108(8):e56; author reply e56. PubMed ID: 12939246
    [No Abstract]   [Full Text] [Related]  

  • 16. The present state of aspirin and clopidogrel resistance.
    Guyer KE
    Hamostaseologie; 2009 Aug; 29(3):285-90. PubMed ID: 19644597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clopidogrel as adjunctive medication in patients with acute coronary syndrome].
    Gulba DC; Lankes W
    Internist (Berl); 2002 Dec; 43(12):1615-8. PubMed ID: 12894751
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined pharmacologic treatment with clopidogrel and statin for patients with acute coronary syndrome: is there a survival advantage?
    Almsherqi Z; McLachlan C; Mossop PJ; Deng Y
    Eur Heart J; 2005 Sep; 26(18):1932; author reply 1933. PubMed ID: 16043449
    [No Abstract]   [Full Text] [Related]  

  • 19. Clopidogrel and the CURE results.
    Maggioni AP
    Haematologica; 2001 Nov; 86(11 Suppl 2):40. PubMed ID: 11926775
    [No Abstract]   [Full Text] [Related]  

  • 20. Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design.
    Pettersen AA; Seljeflot I; Abdelnoor M; Arnesen H
    Scand Cardiovasc J; 2004 Dec; 38(6):353-6. PubMed ID: 15804802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.